Market Cap ₹124 Cr.
Stock P/E 0.0
P/B 4.4
Current Price ₹172
Book Value ₹ 39.5
Face Value 10
52W High ₹261
Dividend Yield 0%
52W Low ₹ 70.1
Alkosign Ltd manufactures and sells writing and display forums in India. It offers vertical, horizontal sliding, guide, structured, and independent forums; note boards and associated add-ons; and stands, school benches, desks, and related accessories below the Alkosign, Sit and Study, Brainee, and Ultra- EX logo names, as well as glass white boards under the Glassy-BO logo call. The organisation was founded in 2020 and is primarily based in Thane, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|
Net Sales | 13 | 10 | 21 | |
Other Income | 0 | 0 | 0 | |
Total Income | 13 | 10 | 22 | |
Total Expenditure | 12 | 9 | 19 | |
Operating Profit | 1 | 1 | 3 | |
Interest | 0 | 1 | 2 | |
Depreciation | 0 | 2 | 2 | |
Exceptional Income / Expenses | 0 | 0 | 0 | |
Profit Before Tax | 1 | -2 | -0 | |
Provision for Tax | 0 | -0 | 0 | |
Profit After Tax | 1 | -1 | -0 | |
Adjustments | 0 | 0 | 0 | |
Profit After Adjustments | 1 | -1 | -0 | |
Adjusted Earnings Per Share | 10.9 | -2.5 | -0.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 110% | 0% | 0% | 0% |
Operating Profit CAGR | 200% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 136% | NA% | NA% | NA% |
ROE Average | -4% | 25% | 25% | 25% |
ROCE Average | 4% | 2% | 2% | 2% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|
Shareholder's Funds | 1 | 13 | 12 |
Minority's Interest | 0 | 0 | 0 |
Borrowings | 9 | 6 | 19 |
Other Non-Current Liabilities | 0 | -0 | -0 |
Total Current Liabilities | 13 | 11 | 3 |
Total Liabilities | 24 | 29 | 34 |
Fixed Assets | 2 | 16 | 18 |
Other Non-Current Assets | 14 | 0 | 1 |
Total Current Assets | 8 | 13 | 15 |
Total Assets | 24 | 29 | 34 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 5 |
Cash Flow from Operating Activities | -4 | -1 | -3 |
Cash Flow from Investing Activities | -16 | -2 | -5 |
Cash Flow from Financing Activities | 20 | 8 | 3 |
Net Cash Inflow / Outflow | 0 | 5 | -5 |
Closing Cash & Cash Equivalent | 0 | 5 | 1 |
# | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|
Earnings Per Share (Rs) | 10.88 | -2.53 | -0.84 |
CEPS(Rs) | 14.12 | 0.52 | 2.74 |
DPS(Rs) | 0 | 0 | 0 |
Book NAV/Share(Rs) | 11.04 | 23.17 | 22.33 |
Core EBITDA Margin(%) | 10.51 | 8.61 | 13.22 |
EBIT Margin(%) | 9.28 | -7.17 | 5.28 |
Pre Tax Margin(%) | 6.92 | -15.47 | -1.77 |
PAT Margin (%) | 5.01 | -13.58 | -2.13 |
Cash Profit Margin (%) | 6.5 | 2.78 | 6.97 |
ROA(%) | 2.82 | -5.22 | -1.44 |
ROE(%) | 98.52 | -20.76 | -3.68 |
ROCE(%) | 5.81 | -2.93 | 3.69 |
Receivable days | 137.66 | 131.5 | 43.38 |
Inventory Days | 62.42 | 97.26 | 107.63 |
Payable days | 98.59 | 77.82 | 23.26 |
PER(x) | 0 | 0 | 0 |
Price/Book(x) | 0 | 1.95 | 3.4 |
Dividend Yield(%) | 0 | 0 | 0 |
EV/Net Sales(x) | 1.54 | 3.46 | 2.85 |
EV/Core EBITDA(x) | 14.28 | 37.67 | 19.79 |
Net Sales Growth(%) | 0 | -23.28 | 110.41 |
EBIT Growth(%) | 0 | -159.27 | 255.13 |
PAT Growth(%) | 0 | -307.88 | 66.95 |
EPS Growth(%) | 0 | -123.29 | 66.95 |
Debt/Equity(x) | 30.4 | 1.27 | 1.68 |
Current Ratio(x) | 0.57 | 1.24 | 4.48 |
Quick Ratio(x) | 0.4 | 0.94 | 1.66 |
Interest Cover(x) | 3.94 | -0.86 | 0.75 |
Total Debt/Mcap(x) | 0 | 0.65 | 0.49 |
# | Mar 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Promoter | 46.49 | 50.41 | 53.21 | 40.32 | 53.28 | 40.32 |
FII | 0 | 0 | 0 | 9.9 | 0.22 | 9.73 |
DII | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 53.51 | 49.59 | 46.79 | 49.78 | 46.5 | 49.95 |
Others | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Promoter | 0.25 | 0.27 | 0.29 | 0.29 | 0.29 | 0.29 |
FII | 0 | 0 | 0 | 0.07 | 0 | 0.07 |
DII | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.29 | 0.27 | 0.25 | 0.36 | 0.25 | 0.36 |
Others | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.54 | 0.54 | 0.54 | 0.72 | 0.54 | 0.72 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About